Disease Status and Interval between Hematopoietic Cell Transplantations Predict Outcome of Pediatric Patients Who Undergo Subsequent Transplantation for Relapsed Hematologic Malignancy.

Autor: Epperly R; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Li Y; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Selukar S; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee., Zeng E; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee., Madden R; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Mamcarz E; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Naik S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Qudeimat A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Sharma A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Talleur A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Dallas MH; Department of Pediatrics, Division of Pediatric Hematology Oncology, University Hospitals Rainbow Babies & Children's Hospital, Cleveland, Ohio; School of Medicine, Case Western Reserve University, Cleveland, Ohio., Gottschalk S; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Srinivasan A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Triplett B; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee. Electronic address: brandon.triplett@stjude.org.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2024 May; Vol. 30 (5), pp. 526.e1-526.e11. Date of Electronic Publication: 2024 Feb 20.

Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8 ⁺ T cell responses.

Autor: Zamora AE; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Crawford JC; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Allen EK; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Guo XJ; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.; Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN 38163, USA., Bakke J; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.; Department of Foundational Sciences, College of Medicine, Central Michigan University, Mount Pleasant, MI 48858, USA., Carter RA; Department of Computational Biology and Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Abdelsamed HA; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Moustaki A; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Li Y; Department of Computational Biology and Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Chang TC; Department of Computational Biology and Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Awad W; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Dallas MH; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Mullighan CG; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Downing JR; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Geiger TL; Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Chen T; Department of Chemical Biology and Therapeutics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Green DR; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Youngblood BA; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Zhang J; Department of Computational Biology and Bioinformatics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA., Thomas PG; Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. paul.thomas@stjude.org.; Integrated Biomedical Sciences Program, University of Tennessee Health Science Center, Memphis, TN 38163, USA.

Publikováno v: Science translational medicine [Sci Transl Med] 2019 Jun 26; Vol. 11 (498).

Treatment of hepatitis C in a pediatric patient using simeprevir and sofosbuvir immediately after an umbilical cord blood transplantation.

Autor: Thomas P; Department of Immunology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA., Santiago T; Department of Pathology, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA., Dallas MH; Department of Bone Marrow Transplantation and Cellular Therapy St. Jude Children's Research Hospital, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.; Department of Pediatrics, University of Tennessee Health Science Center, College of Medicine, Memphis, TN, USA.

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2016 May; Vol. 51 (5), pp. 735-7. Date of Electronic Publication: 2016 Jan 11.

Enhanced cytotoxic function of natural killer and CD3+CD56+ cells in cord blood after culture.

Autor: Tomchuck SL; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Leung WH; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, College of Medicine, Memphis, Tennessee., Dallas MH; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, College of Medicine, Memphis, Tennessee. Electronic address: Mari.Dallas@stjude.org.

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2015 Jan; Vol. 21 (1), pp. 39-49. Date of Electronic Publication: 2014 Oct 18.

Phase I study of the safety and pharmacokinetics of plerixafor in children undergoing a second allogeneic hematopoietic stem cell transplantation for relapsed or refractory leukemia.

Autor: Srinivasan A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee. Electronic address: ashok.srinivasan@stjude.org., Panetta JC; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Cross SJ; Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee., Pillai A; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee., Triplett BM; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee., Shook DR; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee., Dallas MH; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee., Hartford C; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee., Sunkara A; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee., Kang G; Department of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee., Jacobsen J; Department of Pathology, Phoenix Children's Hospital, Phoenix, Arizona., Choi J; Department of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Leung W; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, Tennessee; Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.

Publikováno v: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation [Biol Blood Marrow Transplant] 2014 Aug; Vol. 20 (8), pp. 1224-8. Date of Electronic Publication: 2014 Apr 23.